HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ana Maria Oliveira Battastini Selected Research

Seizures (Absence Seizure)

12/2012A ketogenic diet did not prevent effects on the ectonucleotidases pathway promoted by lithium-pilocarpine-induced status epilepticus in rat hippocampus.
6/2010Effect of ketogenic diet on nucleotide hydrolysis and hepatic enzymes in blood serum of rats in a lithium-pilocarpine-induced status epilepticus.
6/2003Changes in nucleotide hydrolysis in rat blood serum induced by pentylenetetrazol-kindling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ana Maria Oliveira Battastini Research Topics

Disease

25Glioma (Gliomas)
03/2023 - 10/2004
23Neoplasms (Cancer)
01/2024 - 06/2009
8Glioblastoma (Glioblastoma Multiforme)
07/2021 - 06/2009
7Inflammation (Inflammations)
01/2022 - 01/2012
6Urinary Bladder Neoplasms (Bladder Cancer)
10/2023 - 05/2014
5Necrosis
01/2024 - 02/2009
4Neuroinflammatory Diseases
03/2020 - 04/2010
3Overweight
11/2023 - 01/2021
3Bipolar Disorder (Manic Depressive Psychosis)
01/2021 - 12/2016
3Hyperhomocysteinemia
12/2015 - 03/2010
3Epilepsy (Aura)
12/2012 - 06/2003
3Seizures (Absence Seizure)
12/2012 - 06/2003
3Mitochondrial Diseases (Mitochondrial Disease)
12/2012 - 02/2011
3Hypothyroidism
04/2006 - 10/2004
2Carcinogenesis
01/2023 - 09/2014
2Mental Disorders (Mental Disorder)
01/2021 - 09/2004
2Vascular Diseases (Vascular Disease)
09/2020 - 12/2015
2Cardiovascular Diseases (Cardiovascular Disease)
09/2020 - 03/2010
2Mania (Manias)
03/2020 - 01/2016
2Pain (Aches)
01/2016 - 11/2003
2Peripheral Vascular Diseases (Peripheral Vascular Disease)
12/2015 - 12/2013
2Coronary Artery Disease (Coronary Atherosclerosis)
12/2015 - 12/2013
2Thrombosis (Thrombus)
12/2013 - 03/2010
2Status Epilepticus (Complex Partial Status Epilepticus)
12/2012 - 06/2010
2Brain Neoplasms (Brain Tumor)
06/2012 - 08/2007
2Neurodegenerative Diseases (Neurodegenerative Disease)
07/2011 - 04/2010
2Familial Polythelia
10/2009 - 02/2009
2Hyperthyroidism
10/2004 - 11/2003
1Urinary Bladder Diseases (Bladder Diseases)
08/2022
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022
1Chronic Renal Insufficiency
01/2022
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022
1Residual Neoplasm
01/2022
1Hypertension (High Blood Pressure)
01/2022
1Schizophrenia (Dementia Praecox)
01/2021
1Myocardial Infarction
09/2020
1Prostatic Neoplasms (Prostate Cancer)
01/2019

Drug/Important Bio-Agent (IBA)

19Adenosine (Adenocard)FDA LinkGeneric
01/2024 - 06/2003
18Adenosine Triphosphate (ATP)IBA
10/2023 - 01/2002
14EnzymesIBA
10/2023 - 06/2003
115'-Nucleotidase (5' Nucleotidase)IBA
10/2023 - 06/2003
8NucleotidesIBA
03/2023 - 11/2003
7Purinergic Receptors (Receptors, Purine)IBA
08/2022 - 01/2013
7Proteins (Proteins, Gene)FDA Link
01/2022 - 12/2008
7Adenosine Diphosphate (ADP)IBA
01/2020 - 06/2003
7Adenosine Monophosphate (AMP)IBA
01/2020 - 06/2003
4LithiumIBA
01/2021 - 09/2004
3Glucose (Dextrose)FDA LinkGeneric
01/2024 - 07/2023
3purineIBA
10/2023 - 03/2020
3beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA
10/2023 - 11/2013
3Biomarkers (Surrogate Marker)IBA
01/2022 - 09/2014
3Dextroamphetamine (Dexedrine)FDA LinkGeneric
01/2021 - 01/2016
3Purinergic P2X7 ReceptorsIBA
03/2020 - 12/2012
3Apyrase (ATP Diphosphatase)IBA
01/2020 - 06/2003
3Adenine NucleotidesIBA
01/2019 - 02/2005
3monastrolIBA
06/2018 - 10/2013
3Temozolomide (Temodar)FDA LinkGeneric
01/2016 - 02/2009
3Messenger RNA (mRNA)IBA
12/2012 - 12/2008
2Insulin (Novolin)FDA Link
11/2023 - 07/2023
22,6- dichloro- 9- (1- (p- nitrobenzenesulfonyl)- 1,2,3,5- tetrahydro- 4,1- benzoxazepin- 3- yl)- 9H- purineIBA
10/2023 - 07/2021
2PurinesIBA
03/2023 - 08/2007
2nucleotidaseIBA
01/2022 - 06/2010
2NucleotidasesIBA
01/2022 - 02/2017
2LigandsIBA
12/2020 - 06/2018
2SolutionsIBA
11/2020 - 05/2020
2brilliant blue (brilliant blue FCF)IBA
03/2020 - 01/2016
2KinesinsIBA
06/2018 - 04/2014
2Caspase 3 (Caspase-3)IBA
09/2017 - 01/2016
2CytokinesIBA
12/2015 - 05/2015
2HomocysteineIBA
12/2015 - 12/2013
2Conditioned Culture MediaIBA
05/2015 - 07/2011
2GlycosidesIBA
01/2015 - 05/2014
2quinovic acidIBA
01/2015 - 05/2014
2Drinking WaterIBA
09/2014 - 02/2005
2CurcuminIBA
02/2013 - 06/2012
2Anticonvulsants (Antiepileptic Drugs)IBA
12/2012 - 06/2003
2Pilocarpine (Ocusert)FDA LinkGeneric
12/2012 - 06/2010
2adenylyl(3'-5')cytidine-3'-phosphateIBA
01/2012 - 12/2008
2Dihydrotachysterol (AT 10)IBA
10/2009 - 02/2009
1Paclitaxel (Taxol)FDA LinkGeneric
01/2024
1dapagliflozinIBA
01/2024
1Antineoplastic Agents (Antineoplastics)IBA
02/2023
1diphenyl (biphenyl)IBA
01/2023
1ras ProteinsIBA
01/2023
1Biological FactorsIBA
01/2022
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
01/2021
1Interleukin-8 (Interleukin 8)IBA
01/2021
1Methotrexate (Mexate)FDA LinkGeneric
01/2021
1Uric Acid (Urate)IBA
01/2021
1ColchicineFDA LinkGeneric
12/2020
1TubulinIBA
12/2020
1Tubulin ModulatorsIBA
12/2020
1Phosphates (Orthophosphate)IBA
09/2020
1kaempferolIBA
05/2018
1ChitosanIBA
05/2018

Therapy/Procedure

8Therapeutics
01/2024 - 06/2009
4Radiotherapy
08/2022 - 08/2007
3Drug Therapy (Chemotherapy)
01/2021 - 08/2007
2Intranasal Administration
01/2020 - 05/2018
2Ketogenic Diet
12/2012 - 06/2010